| Literature DB >> 29372338 |
Bo Liu1, Yanfang Yang1,2,3, Hongbin Liu4, Zhoutao Xie1, Qun Li1, Meng Deng1, Fangping Li1, Jingling Peng1, Hezhen Wu5,6,7.
Abstract
BACKGROUND: The Acanthaceae family is an important source of therapeutic drugs and ethno medicines. There are many famous medicinal plants from this family, such as Andrographis paniculata, Baphicacanthus cusia, and Dicliptera chinensis. Justicia procumbens (J. procumbens) is widely distributed in tropical and sub-tropical of the world. It has long been used in traditional Chinese medicine for cancer. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed the ethyl acetate extract of J. procumbens had a cytotoxic activity. Therefore, qualitative and quantitative analysis of the chemical constituents in the ethyl acetate extract was important for understanding its pharmacological mechanism.Entities:
Keywords: Chemical constituents; Determinate content; HPLC–DAD–MS; Justicia procumbens; Lignan; Structural analysis
Year: 2018 PMID: 29372338 PMCID: PMC5785455 DOI: 10.1186/s13065-018-0371-z
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Fig. 1The inhibition effect of four extracts on A549 cells. Each value represents the mean ± SD of five separate experiments
Fig. 2HPLC–DAD–ESI–QTOF/MS chromatogram of the ethyl acetate extract of J. procumbens: a UV chromatogram obtained at 205 nm, b TIC chromatogram detected in the positive ion mode
Characterization of 23 compounds in the ethyl acetate extract of J. Procumbens by HPLC–DAD–ESI–MS
| RT (min) | λmax (nm) | Formula | Parent ion | Exact molecular weight | Fragmentation | Identification | |
|---|---|---|---|---|---|---|---|
| 1 | 45.5 | – | C29H42O12 | [M+Na]+ | 605.2578 | 421.2211, 403.2114, 385.2000, 181.0855, 151.0759 | Glycoside of compound 6 |
| 2 | 45.8 | – | C28H40O11 | [M+Na]+ | 575.2471 | 391.2113, 355.1881, 165.0916, 151.0760 | Glycoside of compound 7 |
| 3 | 57.9 | 262 | C26H26O11 | [M+Na]+ | 537.1351 | 353.1012, 335.0906, 307.0968 | Procumbenoside L |
| 4 | 63.1 | 257 | C27H26O12 | [M+Na]+ | 565.1319 | 381.0953, 337.1061 323.0912, 307.0951 | Justicidinoside C |
| 5 | 67.8 | 265 | C27H28O12 | [M+Na]+ | 567.1475 | 383.1113, 369.1001, 365.0987, 339.1217, 337.1064 | Procumbenoside K |
| 6 | 71.5 | – | C23H32O7 | [M+Na]+ | 443.2026 | 403.2015, 385.2002, 247.0938, 217. 0828, 181.0851, 151.0760 | 5-methoxy-4,4′-di- |
| 7 | 73.3 | – | C22H30O6 | [M+Na]+ | 413.1920 | 373.1999, 355.1888, 217.0831, 165.0911, 151.0754 | Secoisolariciresinol dimethyl ether |
| 8 | 74.0 | 263 | C28H28O13 | [M+Na]+ | 595.1420 | 411.1063, 367.1164, 337.1056 | Justicidinoside B |
| 9 | 75.4 | 264 | C32H34O16 | [M+H]+ | 675.1892 | 513.1393, 381.0951 | Procumbenoside B |
| 10 | 87.5 | 265 | C31H32O15 | [M+H]+ | 645.1806 | 513.1393, 381.0952 | Procumbenoside H |
| 11 | 97.8 | 263 | C26H24O11 | [M+H]+ | 513.1395 | 381.0951 | Tuberculatin |
| 12 | 110.1 | 279 | C25H34O8 | [M+Na]+ | 485.2140 | 403.2097, 385.1991, 181.0853, 151.0757 | 5-methoxy-4,4′-di- |
| 13 | 111.5 | 282 | C24H32O7 | [M+Na]+ | 455.2024 | 395.1824, 373.1992, 355.1904, 165.0904, 151.0758 | Secoisolariciresinol dimethyl ether monoacetate |
| 14 | 131.4 | 264 | C26H34O9 | [M+Na]+ | 513.2113 | 371.1845, 339.1584, 233.0795, 217.0843, 177.0910, 167.0702, 151.0758 | Justin C |
| 15 | 131.5 | – | C28H26O12 | [M+H]+ | 555.1495 | 513.1407, 381.0947 | Diphyllin apioside-5-acetate |
| 16 | 149.0 | 258 | C21H16O6 | [M+Na]+ | 387.0824 | 335.0899, 321.0749 | Justicidin B |
| 17 | 155.0 | 201, 228, 278 | C27H36O9 | [M+Na]+ | 527.2250 | 505.2422, 445.2235, 403.2104, 385.1997, 247.0944, 217.0824, 195.1007, 181.0853, 177.0912, 151.0752 | 5-methoxy-4,4′-di- |
| 18 | 156.2 | 201, 230, 280 | C26H34O8 | [M+Na]+ | 497.2147 | 355.1899, 325.1806, 313.1792, 269.1535, 217.0839, 195.1005, 165.0902, 151.0753 | Secoisolariciresinol dimethyl ether diacetate |
| 19 | 159.2 | 262 | C22H18O7 | [M+H]+ | 395.1108 | 365.1015, 351.0859, 319.0972 | Chinensinaphthol methyl ether |
| 20 | 168.3 | 262 | C22H18O7 | [M+H]+ | 395.1110 | 365.1007 | Neojusticin B |
| 21 | 169.9 | 282 | C26H32O9 | [M+Na]+ | 511.1916 | 387.1791, 369.1693, 247.0931, 201.0521, 195.1009, 181.0851, 151.0759 | (−)-dihydroclusin diacetate |
| 22 | 171.0 | 284 | C25H30O8 | [M+Na]+ | 481.1809 | 339.1580, 201.0527, 177.0904, 165.0910, 151.0753, 135.0449 | 2,3-demethoxysecisolintetralin acetate |
| 23 | 171.7 | – | C20H12O6 | [M+H]+ | 349.0648 | 305.0795 | Justicidin E |
Fig. 3Structures of compounds 3–23
Fig. 4Proposed fragmentation pattern of compounds 17 and 18
Fig. 5Pivotal fragment ions of compounds 14, 21, and 22
Fig. 6Characteristic fragment ions of compound 5
1H-NMR data for compounds 4, 8, 9, and 10 (CD3OD)
| Position | 4 | 8 | 9 | 10 |
|---|---|---|---|---|
| δH ( | δH ( | δH ( | δH ( | |
| 4 | 7.73 (s) | |||
| 5 | 7.26 (s) | 7.48 (s) | 7.60 (s) | 7.66 (s) |
| 8 | 6.95 (s) | 6.91 (s) | 6.96 (s) | 7.05 (s) |
| 12 | 5.30 (2H, s) | 5.53 (2H, s) | 5.53 (d, 14.7) | 5.56 (d, 14.8) |
| 2′ | 6.53 (s) | 6.49 (s) | 6.71 (d, 1.2) | 6.78 (d, 2.2) |
| 5′ | 7.02 (s) | 7.01 (s) | 6.86 (d, 7.8) | 6.95 (d, 7.7) |
| 6′ | 6.68 (dd, 1.2, 7.9) | 6.78 (dd, 1.7, 7.0) | ||
| 3′-OCH2O-4′ | 5.94 (s) | 5.93 (s) | 5.96 (s) | 6.05 (s) |
| 4-OCH3 | 4.07 (3H, s) | |||
| 6-OCH3 | 3.89 (3H, s) | 3.89 (3H, s) | 3.94 (3H, s) | 4.02 (s) |
| 7-OCH3 | 3.66 (3H, s) | 3.66 (3H, s) | 3.63 (3H, s) | 3.73 (s) |
| 1′′ | 4.62 (d, 7.8) | 4.59 (d, 8.0) | 5.74 (d, 1.9) | 5.49 (d, 3.6) |
| 2′′ | 2.78 (t, 7.9) | 2.80 (t, 8.6) | 4.68 (d, 2.3) | 4.58 (d, 3.8) |
| 3′′ | 3.21 (m) | 3.21 (m) | ||
| 4′′ | 3.07 (t, 9.4) | 3.08 (t, 9.4) | 4.19 (d, 9.7) | 4.35 (d, 9.6) |
| 5′′ | 3.21 (m) | 3.21 (m) | 4.50 (dd, 11.6) | 4.01 (d, 10.8) |
| 6′′ | 3.49 (2H, dd, 5.8, 11.9) | 3.50 (2H, dd, 5.8, 11.9) | ||
| 1′′′ | 4.52 (d, 7.8) | 4.34 (d, 7.2) | ||
| 2′′′ | 3.14 (m) | 3.29 (t, 11.0) | ||
| 3′′′ | 3.25 (m) | 3.39 (t, 8.4) | ||
| 4′′′ | 3.31 (t, 9.0) | 3.54 (m) | ||
| 5′′′ | 3.41 (m) | 3.92 (dd, 5.2, 10.9) | ||
| 6′′′ | 3.69 (dd, 2.1, 11.6) |
1H-NMR data for compounds 16, 19, and 20 (CD3OD)
| Position | 16 | 20 | Position | 19 |
|---|---|---|---|---|
| δH ( | δH ( | δH ( | ||
| 4 | 7.72 (s) | 4 | ||
| 5 | 7.23 (s) | 7.41 (s) | 5 | 7.35 (s) |
| 8 | 7.01 (s) | 7.00 (s) | 8 | 6.99 (s) |
| 11 | 5.17 (2H, s) | 11 | ||
| 12 | 5.39 (2H, s) | 12 | 5.41 (2H, s) | |
| 2′ | 6.86 (d, 1.5) | 6.85 (d, 1.6) | 2′ | 6.91 (s) |
| 5′ | 6.94 (d, 7.9) | 6.98 (d, 8.0) | 5′ | 7.03 (s) |
| 6′ | 6.80 (dd, 1.5, 7.8) | 6.82 (dd, 1.6, 8.1) | 6′ | 6.76 (dd, 1.6, 8.0) |
| 3′-OCH2O-4′ | 5.98 (s) | 6.06 (s) | 3′-OCH3 | 3.86 (3H, s) |
| 5.94 (s) | 6.00 (s) | 4′-OCH3 | 3.70 (3H, s) | |
| 4-OCH3 | 4.31 (3H, s) | 4-OCH3 | 4.03 (3H, s) | |
| 6-OCH3 | 3.85 (3H, s) | 3.95 (3H, s) | 6-OCH2O-7 | 6.17 (2H, d) |
| 7-OCH3 | 3.64 (3H, s) | 3.72 (3H, s) |
13C (200 MHz) and 1H-NMR (800 MHz) data for compound 12 (CDCl3)
| Position | δC | δH ( | Position | δC | δH ( |
|---|---|---|---|---|---|
| 1 | 136.11 | 1′ | 132.40 | ||
| 2 | 105.70 | 6.29 or 6.30 (d, 1.7) | 2′ | 111.90 | 6.63 (m) |
| 3 | 153.10 | 3′ | 147.33 | ||
| 4 | 153.10 | 4′ | 148.84 | ||
| 5 | 153.10 | 5′ | 111.04 | 6.76 (m) | |
| 6 | 105.70 | 6.29 or 6.30 (d, 1.7) | 6′ | 120.91 | 6.66 (m) |
| 7a | 35.83 | 2.61 (m) | 7′a | 34.99 | 2.65 (m) |
| 2.75 (m) | 7′b | 2.70 (m) | |||
| 8 | 42.97 | 1.95 (m) | 8′ | 39.59 | 2.21 (m) |
| 9 | 62.59 | 3.67 (2H, dtt) | 9′a | 64.69 | 4.06 (ddd) |
| 9′b | 4.24 (ddd) | ||||
| 3-OCH3 | 60.89 | 3.80 (3H, s) | 10′ | 171.05 | |
| 4-OCH3 | 60.89 | 3.80 (3H, s) | 11′ | 21.11 | 2.07 (3H, s) |
| 5-OCH3 | 60.89 | 3.80 (3H, s) | 3′-OCH3 | 55.83 | 3.86 (3H, s) |
| 4′-OCH3 | 56.03 | 3.83 (3H, s) |
Atom numbering as indicated in Fig. 7
All assignments are based on 1H-1H COSY, HSQC, and HMBC data
Fig. 7NMR spectra of compound 12: a chemical structure, b 1H-NMR spectrum, c 13C-NMR spectrum, d HMBC spectrum, e HSQC spectrum, f 1H-1H COSY spectrum
Fig. 8HPLC-UV chromatogram obtained at 260 nm: a sample, b six mixed standard
Linear regression data, LOD, and LOQ of six standard lignans
| Standard | Regression equation | Linear range (μg/ml) | r2 | LOD (μg/ml) | LOQ (μg/ml) |
|---|---|---|---|---|---|
| 4 | Y = 34.3060x − 2.2863 | 3.7–118 | 0.9999 | 0.021 | 0.071 |
| 8 | y = 57.9005x − 3.3266 | 2.6–84 | 0.9999 | 0.013 | 0.044 |
| 10 | y = 13.8900x − 5.3980 | 2.3–74 | 0.9998 | 0.043 | 0.142 |
| 16 | y = 119.9074x − 40.5723 | 5.8–184 | 0.9999 | 0.005 | 0.017 |
| 19 | y = 44.7432x − 18.4394 | 2.1–68 | 0.9998 | 0.017 | 0.057 |
| 20 | y = 19.3973x − 23.6537 | 6.9–220 | 0.9998 | 0.034 | 0.113 |
In the regression equation Y = aX + b, X refers to the concentrations (μg/ml), Y is the peak area
Precision, repeatability, stability, recovery, and content of six standard lignans
| Standard | Precision (RSD %) | Repeatability (RSD %) | Stability (RSD %) | Recovery | Contenta (mg/g) | ||
|---|---|---|---|---|---|---|---|
| Intra-day | Inter-day | Mean | RSD % | ||||
| 4 | 0.86 | 1.63 | 1.78 | 1.39 | 101.49 | 1.66 | 34.70 |
| 8 | 0.99 | 1.37 | 1.93 | 0.88 | 101.20 | 1.97 | 8.93 |
| 10 | 1.10 | 1.85 | 1.96 | 1.16 | 98.63 | 2.00 | 10.10 |
| 16 | 0.64 | 0.99 | 1.31 | 0.73 | 100.51 | 1.53 | 28.36 |
| 19 | 0.92 | 1.72 | 1.81 | 1.57 | 99.37 | 1.95 | 12.22 |
| 20 | 0.51 | 0.94 | 1.35 | 0.94 | 99.04 | 1.83 | 29.05 |
aContent of six lignans in the ethyl acetate extract